1	External	External	B-NP	JJ	O	3	NMOD	0
2	beam	beam	I-NP	NN	O	3	NMOD	0
3	radiotherapy	radiotherapy	I-NP	NN	O	12	SUB	0
4	for	for	B-PP	IN	O	3	NMOD	0
5	subretinal	subretinal	B-NP	JJ	O	6	NMOD	0
6	neovascularization	neovascularization	I-NP	NN	O	4	PMOD	3	neovascularization
7	in	in	B-PP	IN	O	6	NMOD	0
8	age-related	age-related	B-NP	JJ	O	10	NMOD	0
9	macular	macular	I-NP	JJ	O	10	NMOD	0
10	degeneration	degeneration	I-NP	NN	O	7	PMOD	6	degeneration
11	:	:	O	:	O	3	P	0
12	is	be	B-VP	VBZ	O	0	ROOT	0
13	this	this	B-NP	DT	O	14	NMOD	0
14	treatment	treatment	I-NP	NN	O	12	PRD	0
15	efficient	efficient	B-ADJP	JJ	O	14	AMOD	0
16	?	?	O	.	O	12	P	0

1	PURPOSE	PURPOSE	B-NP	NN	O	3	NMOD	0
2	:	:	O	:	O	1	P	0
3	Control	Control	B-NP	NN	O	21	SUB	16	Control
4	of	of	B-PP	IN	O	3	NMOD	0
5	the	the	B-NP	DT	O	7	NMOD	0
6	natural	natural	I-NP	JJ	O	7	NMOD	0
7	course	course	I-NP	NN	O	4	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	subretinal	subretinal	B-NP	JJ	O	10	NMOD	0
10	neovascularization	neovascularization	I-NP	NN	O	8	PMOD	3	neovascularization
11	(	(	O	(	O	13	DEP	0
12	SRNV	SRNV	B-NP	NN	B-protein	13	DEP	0
13	)	)	O	)	O	10	NMOD	0
14	in	in	B-PP	IN	O	10	NMOD	0
15	age-related	age-related	B-NP	JJ	O	17	NMOD	0
16	macular	macular	I-NP	JJ	O	17	NMOD	0
17	degeneration	degeneration	I-NP	NN	O	14	PMOD	6	degeneration
18	(	(	O	(	O	20	DEP	0
19	AMD	AMD	B-NP	NN	O	20	DEP	0
20	)	)	O	)	O	17	NMOD	0
21	is	be	B-VP	VBZ	O	0	ROOT	0
22	difficult	difficult	B-ADJP	JJ	O	21	PRD	0
23	.	.	O	.	O	21	P	0

1	Only	Only	B-NP	RB	O	3	NMOD	0
2	a	a	I-NP	DT	O	3	NMOD	0
3	subset	subset	I-NP	NN	O	6	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	patients	patient	B-NP	NNS	O	4	PMOD	0
6	is	be	B-VP	VBZ	O	0	ROOT	0
7	suitable	suitable	B-ADJP	JJ	O	6	PRD	0
8	for	for	B-PP	IN	O	7	AMOD	0
9	laser	laser	B-NP	NN	O	10	NMOD	0
10	coagulation	coagulation	I-NP	NN	O	8	PMOD	0
11	.	.	O	.	O	6	P	0

1	This	This	B-NP	DT	O	3	NMOD	0
2	prospective	prospective	I-NP	JJ	O	3	NMOD	0
3	study	study	I-NP	NN	O	4	SUB	0
4	aimed	aim	B-VP	VBD	O	0	ROOT	0
5	to	to	I-VP	TO	O	6	VMOD	0
6	determine	determine	I-VP	VB	O	4	VMOD	0
7	the	the	B-NP	DT	O	11	NMOD	0
8	efficacy	efficacy	I-NP	NN	O	11	NMOD	0
9	and	and	O	CC	O	11	NMOD	0
10	individual	individual	B-NP	JJ	O	11	NMOD	0
11	benefit	benefit	I-NP	NN	O	6	OBJ	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	external	external	B-NP	JJ	O	15	NMOD	0
14	beam	beam	I-NP	NN	O	15	NMOD	0
15	radiotherapy	radiotherapy	I-NP	NN	O	12	PMOD	0
16	(	(	O	(	O	18	DEP	0
17	EBRT	EBRT	B-NP	NN	B-protein	18	DEP	0
18	)	)	O	)	O	15	NMOD	0
19	.	.	O	.	O	4	P	0

1	METHODS	METHODS	B-NP	NNS	O	3	NMOD	0
2	AND	AND	I-NP	CC	O	3	NMOD	0
3	MATERIALS	MATERIALS	I-NP	NNS	O	7	NMOD	0
4	:	:	O	:	O	3	P	0
5	The	The	B-NP	DT	O	7	NMOD	0
6	prospective	prospective	I-NP	JJ	O	7	NMOD	0
7	trial	trial	I-NP	NN	O	8	SUB	0
8	included	include	B-VP	VBD	O	0	ROOT	0
9	287	287	B-NP	CD	O	10	NMOD	0
10	patients	patient	I-NP	NNS	O	8	OBJ	0
11	with	with	B-PP	IN	O	10	NMOD	0
12	subfoveal	subfoveal	B-NP	JJ	O	13	NMOD	0
13	neovascularization	neovascularization	I-NP	NN	O	11	PMOD	3	neovascularization
14	due	due	B-ADJP	JJ	O	8	VMOD	0
15	to	to	B-PP	TO	O	14	AMOD	0
16	AMD	AMD	B-NP	NN	O	15	PMOD	0
17	which	which	B-NP	WDT	O	16	NMOD	0
18	was	be	B-VP	VBD	O	17	SBAR	0
19	verified	verify	I-VP	VBN	O	18	VC	0
20	by	by	B-PP	IN	O	19	VMOD	0
21	fluorescein	fluorescein	B-NP	NN	O	22	NMOD	0
22	angiography	angiography	I-NP	NN	O	20	PMOD	0
23	.	.	O	.	O	8	P	0

1	Patients	Patient	B-NP	NNS	O	2	SUB	0
2	have	have	B-VP	VBP	O	0	ROOT	0
3	been	be	I-VP	VBN	O	2	VC	0
4	treated	treat	I-VP	VBN	O	3	VC	19	treated
5	between	between	B-PP	IN	O	4	VMOD	0
6	January	January	B-NP	NNP	O	9	NMOD	0
7	1996	1996	I-NP	CD	O	6	NMOD	0
8	and	and	O	CC	O	9	NMOD	0
9	October	October	B-NP	NNP	O	5	PMOD	0
10	1997	1997	I-NP	CD	O	9	NMOD	0
11	.	.	O	.	O	2	P	0

1	All	All	B-NP	DT	O	2	NMOD	0
2	patients	patient	I-NP	NNS	O	3	SUB	0
3	received	receive	B-VP	VBD	O	0	ROOT	19	received
4	a	a	B-NP	DT	O	6	NMOD	0
5	total	total	I-NP	JJ	O	6	NMOD	0
6	dose	dose	I-NP	NN	O	3	OBJ	0
7	of	of	B-PP	IN	O	6	NMOD	0
8	16	16	B-NP	CD	O	9	NMOD	0
9	Gy	Gy	I-NP	NN	O	7	PMOD	0
10	in	in	B-PP	IN	O	6	NMOD	0
11	2-Gy	2-Gy	B-NP	JJ	O	13	NMOD	0
12	daily	daily	I-NP	JJ	O	13	NMOD	0
13	fractions	fraction	I-NP	NNS	O	10	PMOD	0
14	with	with	B-PP	IN	O	3	VMOD	0
15	5-6	5-6	B-NP	CD	O	17	NMOD	0
16	MeV	MeV	I-NP	NN	O	17	NMOD	0
17	photons	photon	I-NP	NNS	O	14	PMOD	0
18	based	base	B-PP	VBN	O	17	NMOD	0
19	on	on	B-PP	IN	O	18	PMOD	0
20	computerized	computerized	B-NP	JJ	O	22	NMOD	0
21	treatment	treatment	I-NP	NN	O	22	NMOD	0
22	planning	planning	I-NP	NN	O	19	PMOD	0
23	in	in	B-PP	IN	O	22	NMOD	0
24	individual	individual	B-NP	JJ	O	27	NMOD	0
25	head	head	I-NP	NN	O	27	NMOD	0
26	mask	mask	I-NP	NN	O	27	NMOD	0
27	fixation	fixation	I-NP	NN	O	23	PMOD	0
28	.	.	O	.	O	3	P	0

1	This	This	B-NP	DT	O	3	NMOD	0
2	first	first	I-NP	JJ	O	3	NMOD	0
3	analysis	analysis	I-NP	NN	O	4	SUB	0
4	is	be	B-VP	VBZ	O	0	ROOT	0
5	based	base	I-VP	VBN	O	4	VC	0
6	on	on	B-PP	IN	O	5	VMOD	0
7	73	73	B-NP	CD	O	8	NMOD	0
8	patients	patient	I-NP	NNS	O	6	PMOD	0
9	(	(	O	(	O	20	DEP	0
10	50	50	B-NP	CD	O	11	NMOD	0
11	women	woman	I-NP	NNS	O	19	NMOD	0
12	,	,	O	,	O	19	P	0
13	23	23	B-NP	CD	O	14	NMOD	0
14	men	man	I-NP	NNS	O	17	NMOD	0
15	,	,	O	,	O	17	P	0
16	median	median	B-NP	JJ	O	17	NMOD	0
17	age	age	I-NP	NN	O	19	NMOD	0
18	74.3	74.3	B-NP	CD	O	19	NMOD	0
19	years	year	I-NP	NNS	O	20	DEP	0
20	)	)	O	)	O	8	NMOD	0
21	,	,	O	,	O	5	P	0
22	with	with	B-PP	IN	O	5	VMOD	0
23	a	a	B-NP	DT	O	25	NMOD	0
24	median	median	I-NP	JJ	O	25	NMOD	0
25	follow-up	follow-up	I-NP	NN	O	32	NMOD	0
26	of	of	B-PP	IN	O	25	NMOD	0
27	13.3	13.3	B-NP	CD	O	28	NMOD	0
28	months	month	I-NP	NNS	O	26	PMOD	0
29	and	and	O	CC	O	32	NMOD	0
30	a	a	B-NP	DT	O	32	NMOD	0
31	minimum	minimum	I-NP	JJ	O	32	NMOD	0
32	follow-up	follow-up	I-NP	NN	O	22	PMOD	0
33	of	of	B-PP	IN	O	32	NMOD	0
34	11	11	B-NP	CD	O	35	NMOD	0
35	months	month	I-NP	NNS	O	33	PMOD	0
36	.	.	O	.	O	4	P	0

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	All	All	B-NP	DT	O	4	NMOD	0
4	patients	patient	I-NP	NNS	O	5	SUB	0
5	completed	complete	B-VP	VBD	O	1	NMOD	0
6	therapy	therapy	B-NP	NN	O	8	NMOD	19	therapy
7	and	and	I-NP	CC	O	8	NMOD	0
8	tolerability	tolerability	I-NP	NN	O	5	OBJ	0
9	was	be	B-VP	VBD	O	5	VMOD	0
10	good	good	B-ADJP	JJ	O	9	PRD	0
11	.	.	O	.	O	1	P	0

1	First	First	B-NP	JJ	O	3	NMOD	0
2	clinical	clinical	I-NP	JJ	O	3	NMOD	0
3	control	control	I-NP	NN	O	7	SUB	0
4	with	with	B-PP	IN	O	3	NMOD	0
5	second	second	B-NP	JJ	O	6	NMOD	0
6	angiography	angiography	I-NP	NN	O	4	PMOD	0
7	was	be	B-VP	VBD	O	0	ROOT	0
8	performed	perform	I-VP	VBN	O	7	VC	0
9	6	6	B-NP	CD	O	10	NMOD	0
10	weeks	week	I-NP	NNS	O	8	VMOD	0
11	after	after	B-PP	IN	O	10	NMOD	0
12	irradiation	irradiation	B-NP	NN	O	11	PMOD	0
13	,	,	O	,	O	8	P	0
14	then	then	B-ADVP	RB	O	8	VMOD	0
15	in	in	B-PP	IN	O	8	VMOD	0
16	3-month	3-month	B-NP	JJ	O	17	NMOD	0
17	intervals	interval	I-NP	NNS	O	15	PMOD	0
18	.	.	O	.	O	7	P	0

1	Eighteen	Eighteen	B-NP	CD	O	2	NMOD	0
2	patients	patient	I-NP	NNS	O	7	SUB	0
3	with	with	B-PP	IN	O	2	NMOD	0
4	SRNV	SRNV	B-NP	NN	O	3	PMOD	0
5	refusing	refuse	B-VP	VBG	O	4	NMOD	18	refusing
6	radiotherapy	radiotherapy	B-NP	NN	O	5	OBJ	19	radiotherapy
7	served	serve	B-VP	VBD	O	0	ROOT	0
8	as	as	B-PP	IN	O	7	VMOD	0
9	a	a	B-NP	DT	O	11	NMOD	0
10	control	control	I-NP	NN	O	11	NMOD	0
11	group	group	I-NP	NN	O	8	PMOD	0
12	and	and	O	CC	O	7	VMOD	0
13	were	be	B-VP	VBD	O	7	VMOD	0
14	matched	match	I-VP	VBN	O	13	VC	0
15	with	with	B-PP	IN	O	14	VMOD	0
16	18	18	B-NP	CD	O	18	NMOD	0
17	irradiated	irradiated	I-NP	JJ	O	18	NMOD	19	irradiated
18	patients	patient	I-NP	NNS	O	15	PMOD	0
19	.	.	O	.	O	7	P	0

1	After	After	B-PP	IN	O	10	VMOD	0
2	7	7	B-NP	CD	O	3	NMOD	0
3	months	month	I-NP	NNS	O	1	PMOD	0
4	median	median	B-NP	JJ	O	6	NMOD	0
5	visual	visual	I-NP	JJ	O	6	NMOD	0
6	acuity	acuity	I-NP	NN	O	10	SUB	0
7	(	(	O	(	O	9	DEP	0
8	VA	VA	B-NP	NN	O	9	DEP	0
9	)	)	O	)	O	6	NMOD	0
10	was	be	B-VP	VBD	O	0	ROOT	0
11	20/160	20/160	B-NP	CD	O	10	PRD	0
12	for	for	B-PP	IN	O	11	NMOD	0
13	the	the	B-NP	DT	O	16	NMOD	0
14	irradiated	irradiated	I-NP	JJ	O	16	NMOD	19	irradiated
15	and	and	O	CC	O	16	NMOD	0
16	20/400	20/400	B-NP	CD	O	12	PMOD	0
17	for	for	B-PP	IN	O	16	NMOD	0
18	the	the	B-NP	DT	O	20	NMOD	0
19	untreated	untreated	I-NP	JJ	O	20	NMOD	19	untreated
20	patients	patient	I-NP	NNS	O	17	PMOD	0
21	.	.	O	.	O	10	P	0

1	One	One	B-NP	CD	O	2	NMOD	0
2	year	year	I-NP	NN	O	8	SUB	0
3	after	after	B-PP	IN	O	2	NMOD	0
4	radiotherapy	radiotherapy	B-NP	NN	O	7	NMOD	0
5	final	final	I-NP	JJ	O	7	NMOD	0
6	median	median	I-NP	JJ	O	7	NMOD	0
7	VA	VA	I-NP	NN	O	3	PMOD	0
8	was	be	B-VP	VBD	O	0	ROOT	0
9	20/400	20/400	B-NP	CD	O	8	PRD	0
10	in	in	B-PP	IN	O	9	NMOD	0
11	both	both	B-NP	DT	O	12	NMOD	0
12	groups	group	I-NP	NNS	O	10	PMOD	0
13	.	.	O	.	O	8	P	0

1	CONCLUSION	CONCLUSION	B-NP	NN	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	These	These	B-NP	DT	O	4	NMOD	0
4	results	result	I-NP	NNS	O	5	SUB	0
5	suggest	suggest	B-VP	VBP	O	1	NMOD	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	16	16	B-NP	CD	O	8	NMOD	0
8	Gy	Gy	I-NP	NN	O	15	SUB	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	conventionally	conventionally	B-NP	RB	O	11	AMOD	0
11	fractionated	fractionate	I-NP	VBN	O	14	NMOD	0
12	external	external	I-NP	JJ	O	14	NMOD	0
13	beam	beam	I-NP	NN	O	14	NMOD	0
14	irradiation	irradiation	I-NP	NN	O	9	PMOD	0
15	slows	slow	B-VP	VBZ	O	6	SBAR	0
16	down	down	B-PRT	RP	O	15	VMOD	0
17	the	the	B-NP	DT	O	19	NMOD	0
18	visual	visual	I-NP	JJ	O	19	NMOD	0
19	loss	loss	I-NP	NN	O	15	OBJ	0
20	in	in	B-PP	IN	O	19	NMOD	0
21	exudative	exudative	B-NP	JJ	O	22	NMOD	0
22	AMD	AMD	I-NP	NN	O	20	PMOD	0
23	for	for	B-PP	IN	O	22	NMOD	0
24	only	only	B-NP	RB	O	26	AMOD	0
25	a	a	I-NP	DT	O	26	AMOD	0
26	few	few	I-NP	JJ	O	27	NMOD	0
27	months	month	I-NP	NNS	O	23	PMOD	0
28	.	.	O	.	O	1	P	0

1	Patients	Patient	B-NP	NNS	O	2	NMOD	0
2	'	'	B-NP	POS	O	4	NMOD	0
3	reading	reading	I-NP	NN	O	4	NMOD	0
4	vision	vision	I-NP	NN	O	5	SUB	0
5	could	could	B-VP	MD	O	0	ROOT	0
6	not	not	I-VP	RB	O	5	VMOD	0
7	be	be	I-VP	VB	O	5	VC	0
8	saved	save	I-VP	VBN	O	7	VC	0
9	for	for	B-PP	IN	O	8	VMOD	0
10	a	a	B-NP	DT	O	12	NMOD	0
11	long-term	long-term	I-NP	JJ	O	12	NMOD	0
12	run	run	I-NP	NN	O	9	PMOD	0
13	.	.	O	.	O	5	P	0

